Early SGLT2 inhibitor use is associated with improved left atrial strain following acute coronary syndrome
CONCLUSION: In patients with ACS and T2D, addition of empagliflozin to standard ACS therapy prior to discharge is associated with improved LA function.PMID:38456717 | DOI:10.1080/00015385.2024.2324221
Source: Acta Cardiologica - Category: Cardiology Authors: Amro Sehly Albert He Abdul Rahman Ihdayhid Christine Grey Scott O'Connor Gillian Green Matthew Erickson James M Rankin P Gerry Fegan Bu B Yeap Girish Dwivedi Nick S R Lan Source Type: research
More News: Cardiology | Diabetes | Diabetes Type 2 | Empagliflozin | Endocrinology | Heart | Heart Failure | Jardiance | SGLT2 Inhibitors